Fortress Investment Group LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 85 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Fortress Investment Group LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,563,000
-44.1%
809,651
-14.1%
0.16%
+2.6%
Q1 2022$2,798,000
-33.9%
942,2580.0%0.15%
-6.2%
Q4 2021$4,231,000
+100.7%
942,258
+117.2%
0.16%
+36.1%
Q3 2021$2,108,000
-28.7%
433,8040.0%0.12%
-2.5%
Q2 2021$2,958,000
-3.4%
433,8040.0%0.12%
-16.4%
Q1 2021$3,062,000
+12.7%
433,8040.0%0.15%
+20.7%
Q4 2020$2,716,000
+15.8%
433,8040.0%0.12%
-19.3%
Q3 2020$2,346,000
+3.6%
433,8040.0%0.15%
-30.9%
Q2 2020$2,264,000
+65.7%
433,8040.0%0.22%
+20.6%
Q1 2020$1,366,000
-21.9%
433,8040.0%0.18%
-11.8%
Q4 2019$1,748,000
-6.7%
433,8040.0%0.20%
+4.1%
Q3 2019$1,874,000
+8.3%
433,8040.0%0.20%
+3.7%
Q2 2019$1,730,000
-25.6%
433,8040.0%0.19%
-20.3%
Q1 2019$2,326,000
+4.5%
433,8040.0%0.24%
-12.5%
Q4 2018$2,226,000
-47.1%
433,8040.0%0.27%
-34.1%
Q3 2018$4,208,000
-4.9%
433,8040.0%0.41%
+122.2%
Q2 2018$4,424,000
-21.6%
433,8040.0%0.18%
+27.6%
Q1 2018$5,640,000
-27.4%
433,8040.0%0.14%
-28.2%
Q4 2017$7,766,000
-28.7%
433,8040.0%0.20%
-15.5%
Q3 2017$10,888,000
+4.2%
433,8040.0%0.24%
+11.7%
Q2 2017$10,454,000
+25.2%
433,8040.0%0.21%
+613.3%
Q1 2017$8,350,000
+25.0%
433,8040.0%0.03%
-80.8%
Q4 2016$6,680,000
+18.4%
433,8040.0%0.16%
+30.0%
Q3 2016$5,644,000
-6.5%
433,8040.0%0.12%
-23.1%
Q2 2016$6,034,000
-8.3%
433,8040.0%0.16%
+4.7%
Q1 2016$6,581,000433,8040.15%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders